Skip to main content

Table 1 Baseline characteristics of study participants

From: Diaphragmatic excursion is correlated with the improvement in exercise tolerance after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease

 

All

Responders

Non-responders

p value

n = 50

n = 30

n = 20

Age, year

74.9 ± 5.7

74.6 ± 5.8

75.3 ± 5.7

0.95

Gender, male/female (%)

44/6 (88/12)

28/2 (93/7)

16/4 (81/19)

0.16

BMI, kg/m2

22.1 ± 3.6

22.0 ± 2.8

22.3 ± 4.7

0.80

GOLD (I + II/III/IV)

27/17/6

20/8/2

7/9/4

0.07

LTOT, n (%)

5 (10)

3 (10)

2 (10)

0.89

CAT

14 (10–20)

11.5 (8.8–16.8)

18.5 (12.3–20.8)

0.04

FVC %predicted

93.0 ± 20.2

97.3 ± 19.5

86.4 ± 20.0

0.06

FEV1 %predicted

56.0 ± 21.8

63.2 ± 21.8

45.1 ± 17.1

0.003

SpO2, %

90 ± 7

91 ± 7

90 ± 6

0.55

%LAA

17.5 ± 16.3

17.0 ± 14.6

18.2 ± 19.0

0.65

6MWD, m

378 ± 88

411 ± 83

328 ± 71

< 0.001

mBorg scale dyspnoea

5 (4–7)

4 (3–7)

6 (4–8)

0.007

mBorg scale leg fatigue

2 (1–5)

2 (0.9–4)

2.5 (1.3–5)

0.50

PImax, cmH2O

55.7 ± 21.9

65.7 ± 19.4

40.6 ± 16.2

< 0.001

DEmax, mm

47.9 ± 9.3

52.9 ± 7.8

40.4 ± 5.3

< 0.001

QMS, kgf/kg

0.54 ± 0.14

0.58 ± 0.13

0.48 ± 0.13

0.007

  1. COPD chronic obstructive pulmonary disease, BMI body mass index, GOLD Global Initiative for Chronic Obstructive Lung Disease, LTOT long-term oxygen therapy, CAT COPD assessment test, FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, SpO2 saturation of percutaneous oxygen, LAA low attenuation area, 6MWD 6-min walk distance, mBorg modified Borg, PImax maximum inspiratory pressure, DEmax maximum diaphragmatic excursion, QMS quadriceps muscle strength. Values are presented as means ± standard deviations or median (inter-quartile)